Compounds > 7-ethyl-7-hydroxy-10h-1-3-dioxolo(4-5-g)pyrano(3--4--6-7)indolizino(1-2-b)quinoline-8-11(7h-12h)-dione

7-ethyl-7-hydroxy-10h-1-3-dioxolo(4-5-g)pyrano(3--4--6-7)indolizino(1-2-b)quinoline-8-11(7h-12h)-dione and Multiple-Myeloma

7-ethyl-7-hydroxy-10h-1-3-dioxolo(4-5-g)pyrano(3--4--6-7)indolizino(1-2-b)quinoline-8-11(7h-12h)-dione has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for 7-ethyl-7-hydroxy-10h-1-3-dioxolo(4-5-g)pyrano(3--4--6-7)indolizino(1-2-b)quinoline-8-11(7h-12h)-dione and Multiple-Myeloma

ArticleYear
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.
    Haematologica, 2020, Volume: 105, Issue:2

    Topics: Benzodioxoles; Humans; Indolizines; Multiple Myeloma; Survivin

2020